Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	6.66B -17.4%
Revenue (ttm)	3.68B -8.3%
Net Income	168.94M -22.9%
EPS	0.16 -25.0%
Shares Out	1.02B
PE Ratio	40.92
Forward PE	27.68
Dividend	0.06 (0.84%)
Ex-Dividend Date	n/a

Volume	14,116,772
Average Volume	6,456,162
Open	6.71
Previous Close	6.79
Day's Range	6.46 - 6.72
52-Week Range	6.38 - 9.42
Beta	1.25
RSI	37.05
Earnings Date	Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant ex...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2025, SHA:600223's revenue was 3.65 billion, a decrease of -8.33% compared to the previous year's 3.98 billion. Earnings were 187.75 million, a decrease of -22.90%.